Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Wendall Wierenga

Affiliations

  • Director at Cytokinetics Inc (CYTK), 2020-05-14
  • Director at Crinetics Pharmaceuticals Inc. (CRNX), 2020-04-29
  • Director at Concert Pharmaceuticals Inc. (CNCE), 2018-06-18
  • Director at Apricus Biosciences Inc. (APRI), 2018-01-08
  • Director at Ocera Therapeutics Inc. (OCRX), 2017-12-11
  • Director at Xenoport Inc (XNPT), 2016-07-07
  • Director at Anacor Pharmaceuticals Inc. (ANAC), 2016-06-24
  • Evp, R&d at Santarus Inc (SNTS), 2014-01-06
  • Director at Onyx Pharmaceuticals Inc (ONXX), 2013-10-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OCRX $3.71 5,000 Director 5,000 2015-06-23 Filing
XNPT $5.63 5,000 Director 28,998 2015-05-11 Filing
APRI $1.52 20,000 Director 20,000 2014-10-22 Filing
XNPT $3.99 10,000 Director 23,998 2014-05-27 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CYTK $16.00 6,666 Director 0 2020-04-28 Filing
CYTK $16.00 3,333 Director 0 2020-04-28 Filing
ONXX $77.71 250 Director 9,080 2013-02-01 Filing
ONXX $77.21 250 Director 9,330 2012-11-01 Filing
ONXX $74.09 5,000 Director 9,580 2012-08-24 Filing